Certified by Founder Lodge
Baseimmune
United Kingdom - London, England
START UP
1 Disclosed Funding Rounds $11,402,055
0 Participating Investments
-
Founded date
2019
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Baseimmune was founded in 2019 as a discovery phase start-up in the antigen discovery and vaccine development field.
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| February, 29 ,2024 | Series A | $11,402,055 |
Hoxton Ventures
Maki.vc
IQ Capital
Merck
Creator Fund
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Sizable Energy | $8,000,000 | (Oct 24, 2025)
Sumble | $38,500,000 | (Oct 24, 2025)
Syntracts | $5,300,000 | (Oct 24, 2025)
Cybrid | $10,000,000 | (Oct 24, 2025)
Elevara Medicines | $70,000,000 | (Oct 24, 2025)
